Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/29796Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ghilas, Sonia | - |
| dc.contributor.author | Mielke, Lisa A | - |
| dc.date | 2021 | - |
| dc.date.accessioned | 2022-04-12T04:28:25Z | - |
| dc.date.available | 2022-04-12T04:28:25Z | - |
| dc.date.issued | 2021-12 | - |
| dc.identifier.citation | Trends in immunology 2021; 42(12): 1063-1065 | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/29796 | - |
| dc.description.abstract | In two elegant studies, Tyler Jacks' group and colleagues unveil crucial interactions between dendritic cells and TCF1+CD8+ progenitor T cells, shaping their heterogeneity and offering potential to design new putative cancer immunotherapies and vaccines. | en |
| dc.language.iso | eng | - |
| dc.title | Dendritic cells shape TCF1+CD8+ progenitor T cell heterogeneity. | en |
| dc.type | Journal Article | en |
| dc.identifier.journaltitle | Trends in immunology | en |
| dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en |
| dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/34774417/ | en |
| dc.identifier.doi | 10.1016/j.it.2021.10.013 | en |
| dc.type.content | Text | en |
| dc.identifier.orcid | 0000-0002-0164-2860 | en |
| dc.identifier.orcid | 0000-0002-9522-9320 | en |
| dc.identifier.pubmedid | 34774417 | - |
| item.grantfulltext | none | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.fulltext | No Fulltext | - |
| item.languageiso639-1 | en | - |
| item.openairetype | Journal Article | - |
| item.cerifentitytype | Publications | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.